At a glance
ClinicalIndex Comparison RecordN/ACompleted· 10 enrolled
Drug / intervention
Fluorescein Sodium Injection +3 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Pilot Study of Feasibility of Performing Intravital Microscopy in Melanoma Patients
In Brief
A clinical study evaluating Diagnostic Microscopy, Fluorescein Sodium Injection, and 2 other interventions for Recurrent Melanoma and 9 related conditions. Completed, enrolled 10 participants across 1 site.
Detailed Summary
This pilot clinical trial studies intravital microscopy for identifying tumor vessels in patients with stage IA-IV melanoma that is being removed by surgery. New imaging procedures, such as intravital microscopy, may determine the extent of melanoma.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsRecurrent Melanoma, Stage IA Skin Melanoma, Stage IB Skin Melanoma, Stage IIA Skin Melanoma, Stage IIB Skin Melanoma, Stage IIC Skin Melanoma, Stage IIIA Skin Melanoma, Stage IIIB Skin Melanoma, Stage IIIC Skin Melanoma, Stage IV Skin Melanoma
CountriesUnited States
CollaboratorsNational Cancer Institute (NCI)
Timeline
N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedJun 2013
Enrollment StartSep 2013
Primary CompletionJun 2015
Study CompletionMay 2020
TodayJul 2026
First PostedJun 25, 2013
Enrollment StartSep 4, 2013
Primary CompletionJun 16, 2015
Study CompletionMay 6, 2020
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 13.0 years ago
Interventions
Diagnostic Microscopyprocedure
Undergo intravital microscopy
Fluorescein Sodium Injectiondrug
Given IV
Laboratory Biomarker Analysisother
Correlative studies
Therapeutic Conventional Surgeryprocedure
Undergo surgery